Title: Thumbi Ndungu, BVM, PhD
1New Minds, New Ideas Attracting the Next
Generation of Investigators to HIV Vaccine
Research
Thumbi Ndungu, BVM, PhD Doris Duke Medical
Research Institute University of KwaZulu Natal
2Challenges Facing African Investigators
Challenges Facing African Investigators
- Although HIV/AIDS is overwhelmingly an African
problem, very few Africans are involved in HIV
Vaccine Research - There is a moral obligation for Africans to get
involved and for the global research community
to address this disparity. What are the
challenges and how do we address them?
3Challenges Facing African Investigators
- Limited research infrastructure
- Limited political will by African governments
and institutions - Lack of capacity for mentorship and
grantsmanship
4Challenges Facing African Investigators
Challenges Facing African Investigators
- Limited opportunities for career growth-
leading to brain drain, vicious cycle - Economic issues such as poor salaries and
cumbersome bureaucracies - Paucity of rigorous academic/research
environments
5Opportunities
- In some cases, it is easier and faster to do HIV
vaccine research in Africa - study cohorts,
cooperative and enthusiastic collaborators who
understand the need - Opportunities for direct impact on communities
and institutions
6Solutions
- Investment in local leadership development
- Local ownership and attributable credits by
collaborators - Long-term partnerships - facilitators rather than
competitors sustainable funding Centers of
Excellence exchange programs that work in both
directions
7Profile of an African in HIV Research
- Degrees from Nairobi and Harvard
- Seed funding from Harvard for a junior faculty
position in Botswana - Great collaborations and facilitation from
mentors at Harvard in Botswana and South Africa
8 The Doris Duke Medical Research Institute
(DDMRI) in Durban, South Africa. The facility
houses the HIV Pathogenesis Programme, a
collaborative initiative between Massachusetts
General Hospital and the Nelson Mandela School of
Medicine